Brazil and Argentina tapped to make mRNA vaccines in Latin America


  • World
  • Wednesday, 22 Sep 2021

FILE PHOTO: The word "COVID-19" is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration

BRASILIA (Reuters) - The Pan American Health Organization (PAHO) has selected two biomedical centers in Argentina and Brazil as regional hubs to develop and produce mRNA-based vaccines to fight COVID-19 in Latin America, the regional health agency said on Tuesday.

The idea is to tap existing manufacturing capacities to help transfer vaccine technology developed by Moderna in the United States to a region badly hit by the coronavirus and still without access to enough vaccines.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Trump's three US Supreme Court appointees thrash out immunity claim
Intel reports revenue increase in first quarter
Microsoft reports Q3 results with net income, revenue increases
Finland's finance ministry downgrades growth forecast for 2024
Multiple people killed in car crash in U.S. Pleasanton
U.S. stocks close lower
Czech Republic records over 10,000 whooping cough cases this year
Roundup: U.S. witnesses bird flu outbreaks in poultry, dairy cows
US and allies aim to help Ukraine bolster defenses after aid gap
5 Tunisian fishermen dead after boat sank off eastern coast

Others Also Read